• 143. San Antonio Breast Cancer Symposium 2024 - Part 2

  • Feb 1 2025
  • Length: 21 mins
  • Podcast

143. San Antonio Breast Cancer Symposium 2024 - Part 2

Listen for free

View show details

  • Summary

  • Our second SABCS (San Antonio Breast Cancer Symposium) episode covers everything (else) you need to know from 2024.


    In this episode, we dive into the role of trastuzumab deruxtecan in HR +ve, HER2 low cancers, perioperative atezolizumab in tnbc, the use of a novel ADC (SHR-A1811) and the role of tumour mutational burden in triple-negative cancer.


    Studies discussed in the episode:

    DESTINY-Breast06

    Neoadj atezo

    FASCINATE-N

    KEYNOTE-522


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.


    Hosted on Acast. See acast.com/privacy for more information.
    Show more Show less
Show more Show less

What listeners say about 143. San Antonio Breast Cancer Symposium 2024 - Part 2

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available